Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.09

(11.25%)

FLWS

$5.71

(8.76%)

ACCO

$4.21

(2.56%)

ARLP

$23.86

(1.25%)

AUIAF

$0.1

(0.37%)

AZZ

$116.39

(2.68%)

BTBT

$3.16

(4.29%)

BTM

$3.88

(-0.9%)

CVKD

$13.34

(5.54%)

LCE:CA

$0.28

(1.82%)

COCP

$1.25

(2.95%)

CDRO

$7.24

(4.93%)

CVGI

$1.98

(5.05%)

LODE

$2.96

(3.32%)

CMTL

$2.51

(3.29%)

CNDT

$2.9

(3.57%)

CXW

$21

(1.6%)

CMLS

$0.14

(14.17%)

DRCT

$0.4

(-0.6%)

DLHC

$5.93

(1.19%)

SSP

$2.8

(-1.41%)

ELDN

$2.47

(1.65%)

EVC

$2.46

(1.23%)

EDRY

$12.73

(1.92%)

ESEA

$63.37

(-0.31%)

FAT

$1.92

(0.52%)

RAIL

$8.75

(0.46%)

GDEV

$17.36

(3.88%)

GOVX

$0.69

(0.88%)

GOCO

$4.89

(1.88%)

GHM

$54.35

(3.96%)

GLDD

$12.2

(1.96%)

GYRE

$7.02

(1.45%)

HMENF

$1.54

(6.94%)

III

$5.5

(2.14%)

IPOOF

$9.04

(-1.54%)

KELYA

$14.18

(1.87%)

KTOS

$78.58

(3.74%)

LUCK

$9.71

(-0.21%)

MAIA

$1.58

(2.92%)

MGROF

$0.46

(0%)

NTRB

$7.02

(1.45%)

OCGN

$1.39

(4.92%)

PERF

$1.96

(-0.51%)

QMCI

$0.15

(0%)

RGP

$5.46

(3.41%)

SGA

$12.23

(0%)

SHWZ

(0%)

SHIP

$9.02

(1.23%)

SLQT

$2.12

(3.68%)

SKYX

$1.31

(1.15%)

SNAL

$0.97

(4.47%)

GEO

$22.17

(2.59%)

ODP

$22.02

(1.57%)

TNXP

$28.53

(2.96%)

TSQ

$6.83

(-0.15%)

TZOO

$10.25

(5.05%)

UNCY

$4.04

(-0.06%)

VVX

$59.25

(3.58%)

VNCE

$2.8

(9.8%)

XELB

$1.41

(-2.08%)

ZOMDF

$0.09

(11.25%)

FLWS

$5.71

(8.76%)

channelchek-in

‌

9/18/2025

Roche to Acquire 89bio in $3.5 Billion Deal to Advance MASH Treatment Pipeline

Swiss pharmaceutical leader Roche has announced an agreement to acquire clinical-stage biopharmaceutical company 89bio, Inc. in a deal valued at up to $3.5 billion. The acquisition is set to strengthen Roche’s cardiovascular, renal, and metabolism portfolio, particularly its capabilities in treating metabolic dysfunction-associated steatohepatitis (MASH).

2 min read